One of the most prominent priorities during the COVID-19 pandemic is sustaining the gains toward HIV epidemic control and ensuring continuity of treatment and support for viral suppression among people living with HIV (PLHIV), including members of key populations (KPs).
This webinar, the first in a series on the topic of COVID-19 and HIV, is organized by the International AIDS Society (IAS) and will be held on Friday, April 3, from 10 - 11:30 am SAST. The webinar is openly recommended to HIV professionals, government representatives working in the field of HIV, public health specialists, programme managers, service providers, civil society representatives and members of organizations supporting key and vulnerable populations.
The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) is deeply committed to continuing global progress toward controlling the HIV epidemic – country by country, community by community. As we join the world in confronting the unique challenges posed by the novel coronavirus (COVID-19), we are dedicated to doing what is needed to serve, support, and protect our clients, communities, staff, and partners around the world.
Boost is a mobile phone app and website designed and developed in collaboration with community health workers and peer educators in southern Africa. Boost provides easy, up-to-date, visual and interactive materials on HIV and sexual health.
By adapting services to client needs, differentiated antiretroviral therapy (DART) has the potential to use resources more efficiently. We conducted a systematic review assessing the cost of DART in sub-Saharan Africa compared with the standard of care.
The annual INTEREST Conference is the premier scientific conference for HIV in Africa and brings together scientists involved in HIV treatment, pathogenesis, and prevention research from around the world.
The World Health Organization recommends "same-day" initiation of antiretroviral therapy (ART) for HIV patients who are eligible and ready. Identifying efficient, safe, and feasible procedures for determining same-day eligibility and readiness is now a priority. The Simplified Algorithm for Treatment Eligibility (SLATE) study evaluated a clinical algorithm that allows healthcare workers to determine eligibility for same-day treatment and to initiate ART at the patient’s first clinic visit.
Half of those attending HIV clinics in South Africa and Kenya were eligible to start HIV treatment after simple checks that could be performed by any healthcare worker, and same-day treatment initiation modestly improved the uptake of antiretroviral therapy (ART), results of a randomised trial pu